 The study published in the Journal of the American Medical Association compared patients with type 2 diabetes and treated with insulin against patients taking the class of drugs which includes medications like Ozempic. The researchers report those who received the Ozempic class of drugs had a significantly lower risk of developing 10 out of 13 cancers studied. Those include kidney, pancreatic, esophageal, ovarian, liver, and colorectal cancer.